Top 5 Small Cap Stocks To Own Right Now

On Wednesday, our Under the Radar Moversnewsletter suggested shorting small cap trust stock Cross Timbers Royalty Trust (NYSE: CRT):

On the close-up detailed chart of Cross Timber Royalty we can see how well-developed the downtrend is, but what’s so eye-catching is the way the selling volume is starting to build on the way down. The recent bearish crosses of all the key moving average lines were indeed telling of trouble.

The recent weakness means so much more in the context of a longer-term chart though, so take a look at the weekly chart of CRT going back to 2011. As you can see, once the stock breaks under its key long-term moving average lines, it usually doesn’t stop. It’s possible Cross Timber Royalty shares could be revisiting the low around $12.00 hit in late 2015 and early 2016 fairly soon.

Top 5 Small Cap Stocks To Own Right Now: Panera Bread Company(PNRA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer wanted to talk a little psychology. With its after-hours move Tuesday, Panera Bread (PNRA) is up more than 16% this week on takeover speculation. Panera is an old Action Alerts PLUS name, one the trust sold at a nice gain, too. 

  • [By Ben Levisohn]

    Keurigs plight (actually, JABs) is worsening, with the K-cup market slowing to almost no growth now, and Keurig continuing to lose own brands share. Starbucks (SBUX) echoed the notion of a K-cup market slowdown at its seminar on Wednesday (and is guiding for its [consumer packaged goods, or CPG,] growth below recent trends), but it expects to increase its share of total CPG coffee to 20% from 15%. Come early February it will be a year since the closing of the Keurig deal for JAB Holdings. The pressure on JAB is more significant if we take into account the high leverage of the deal (JAB contributed one fourth of the $12Bn price tag). It is a tough predicament. On the one hand we argue that to make that deal work, they need to buy more (own) brands either from the retail channel (that can be extended to CPG: Dunkin (DNKN)? Panera (PNRA)?), or outright buy CPG brands (like the entire Kraft Heinz portfolio, and or Tata Groups Eight OClock brand). But can/how do they fund these deals? Maybe Mars and Warren Buffett (Mars is involved in office coffee with Starbucks), private equity, and or 3G can help? While this note is not about Positive-rated Mondelez, we have mentioned before a scenario where Kraft Heinz buys Mondelez and partly funds the deal by selling its own CPG coffee business (~$3Bn we say) to JAB as well as divests the Mondelez 20% plus stakes in Keurig (North America) and Jacobs Douwe Egberts (Western Europe), which together at this stage are worth ~$7-8Bn. But, yes, JAB will need deep-pocket partners and generous lenders. Net, JAB needs to do something soon.

  • [By Motley Fool Staff]

    In this segment fromMarket Foolery, host Chris Hill is joined by Motley Fool analystDavid Kretzmann as they break down how coffee-and-pastry focused JAB Holding Company will fit a fast casual brand into its privately held portfolio. With the acquisition, the JAB is expected to give thePanera Bread(NASDAQ:PNRA)team even more autonomy than usual.

  • [By WWW.THESTREET.COM]

    Then there’s Panera Bread (PNRA) , a company that had lost its way. But after interviewing Panera’s CEO Ron Shaich, Cramer learned that at its new, remodeled “Panera 2.0” stores, the lines were out the door. As the rollout continued, earnings only got stronger. Never underestimate the power of a restaurant redo, Cramer concluded.

  • [By Billy Duberstein]

    In late March, the company informed investors that after a two-year undertaking, it had finally removed all preservatives from its tortillas, making the Chipotle menu completely preservative-free. The company also called out competitors McDonald’s (NYSE: MCD) and Panera Bread (NASDAQ: PNRA) for marketing their menus as “natural,” as Chipotle insisted these other restaurants still use preservatives made in a lab.

  • [By Seth McNew]

    Other companies have followed suit with great success, including PaneraBread (NASDAQ:PNRA), which has focused on improving the customer experience, including via shorter wait times. Panera 2.0 was largely successful because of the company’s focus on its digital strategy and Chipotle looks to be doing the same thing.

Top 5 Small Cap Stocks To Own Right Now: FuelCell Energy Inc.(FCEL)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap fuel cell stockFuelCell Energy Inc (NASDAQ: FCEL) reportedQ2 2017 earnings before the market opened with shares up in premarket trading. Total revenueswere $20.4 million versus $28.6 million with the revenue components being:

  • [By Peter Graham]

    The Q1 2017 earnings report for small cap fuel cell stockFuelCell Energy Inc (NASDAQ: FCEL) is scheduled forbefore the marketopens onThursday (March 9th). Last December,FuelCell Energy announced a business restructuring to reduce costs and align production levels with current levels of demand in a manner that is consistent with the Companys long-term strategic plan.The Company said it cut 96 jobs, or 17% of its workforce, and has halved production to 25 megawatts a year in order to position for delays in order flow.

  • [By Peter Graham]

    Small cap fuel cell stockFuelCell Energy Inc (NASDAQ: FCEL) reported Q4 and fiscal year ended October 31, 2017 earningswithQ4 total revenuesbeing $47.9 million versus $24.5 million:

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a new 52-week low of $1.00 on Friday, down 60% compared with Thursday’s closing price of $1.60. The stock’s 52-week high is $8.88. Volume of around 12.4 million shares was about 13 times the daily average of around 800,000 shares. The company priced a secondary stock offering of 12 million shares and additional warrants at $1.28 to raise $15.4 million.

Top 5 Small Cap Stocks To Own Right Now: Rackspace Hosting Inc(RAX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Rackspace Hosting, Inc. (NYSE: RAX) reported better-than-expected earnings for the first quarter, but the company missed analysts’ sales estimates. Rackspace shares dropped 7.72 percent to $20.80 in the after-hours trading session.

Top 5 Small Cap Stocks To Own Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors’ Opinion:

  • [By Max Byerly]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.

  • [By Shane Hupp]

    Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.

Top 5 Small Cap Stocks To Own Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) dropped about 6.9% Friday to post a new 52-week low of $2.69 after closing at $2.89 on Thursday. The 52-week high is $5.66. Volume was around 6.2 million, more than three times the daily average of around 1.9 million. The company had no specific news.

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Ben Levisohn]

    We updated our annual U.S. Hep C survey in early July, in order to gauge the future for Gilead, AbbVie/Enanta Pharmaceuticals (ENTA), Merck, and J&J/Achillion Pharmaceuticals (ACHN). In conjunction with script trends, physicians indicate that the market for treatment-eligible, easily accessible Hep C patients is shrinking, but that Gilead’s share of the shrinking pie is continuing to grow. With no end to script declines in sight, we are left wondering where the Hep C will bottom…

Leave a Reply

Your email address will not be published. Required fields are marked *